Nissay Asset Management Corp Japan ADV Boosts Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Nissay Asset Management Corp Japan ADV has increased its stake in Mettler-Toledo International by 23.3%, owning approximately 0.08% of the company, valued at about $20.57 million.
• Analysts have given Mettler-Toledo a consensus rating of "Moderate Buy" with a price target of $1,311.11, while notable upgrades include Citigroup raising its target to $1,600.00.
• Insider selling activity includes CFO Shawn Vadala selling 300 shares at an average price of $1,254.09, showing a decrease in ownership by 5.56%.

Nissay Asset Management Corp Japan ADV lifted its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 23.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,417 shares of the medical instruments supplier's stock after purchasing an additional 3,289 shares during the period. Nissay Asset Management Corp Japan ADV owned 0.08% of Mettler-Toledo International worth $20,568,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of MTD. Mercer Global Advisors Inc. ADV boosted its holdings in shares of Mettler-Toledo International by 13.2% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 480 shares of the medical instruments supplier's stock valued at $588,000 after purchasing an additional 56 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Mettler-Toledo International by 9.8% in the fourth quarter. Ameriprise Financial Inc. now owns 70,935 shares of the medical instruments supplier's stock valued at $86,802,000 after purchasing an additional 6,312 shares during the period. Benjamin Edwards Inc. boosted its holdings in shares of Mettler-Toledo International by 8.8% in the fourth quarter. Benjamin Edwards Inc. now owns 210 shares of the medical instruments supplier's stock valued at $257,000 after purchasing an additional 17 shares during the period. Captrust Financial Advisors raised its stake in Mettler-Toledo International by 11.6% in the fourth quarter. Captrust Financial Advisors now owns 656 shares of the medical instruments supplier's stock worth $802,000 after buying an additional 68 shares in the last quarter. Finally, Cetera Investment Advisers raised its stake in Mettler-Toledo International by 8.7% in the fourth quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier's stock worth $1,315,000 after buying an additional 86 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. This represents a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Gerry Keller sold 165 shares of the company's stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares in the company, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last ninety days. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Trading Up 1.3%

Shares of MTD stock traded up $16.86 during trading hours on Friday, reaching $1,304.65. 95,040 shares of the company's stock were exchanged, compared to its average volume of 126,089. The stock's 50 day moving average is $1,251.17 and its 200-day moving average is $1,185.25. The company has a market cap of $26.88 billion, a price-to-earnings ratio of 33.04, a P/E/G ratio of 3.92 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same period in the prior year, the firm posted $9.65 earnings per share. The business's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on MTD shares. Bank of America boosted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Citigroup boosted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Barclays assumed coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target on the stock. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Mettler-Toledo International presently has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.